{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8NJJ9",
      "entity_text" : "QoR",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5311068",
      "entity_text" : "dexmedetomidine",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Thus, dexmedetomidine administration during VATS can increase QoR, promote quality of life, and lead to a higher satisfaction rate for patients after surgery.",
  "reading_complete" : "2020-07-28T17:38:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:38:04Z",
  "trigger" : "increase",
  "evidence" : [ "dexmedetomidine administration during VATS can increase QoR" ],
  "pmc_id" : "4998651",
  "score" : 0
}